Faruqi & Faruqi, LLP Urges Hims & Hers Health, Inc. (HIMS) Investors to Seek Counsel Before the November 2, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Hims to Contact Him Directly to Discuss Their Options
New York, New York--(Newsfile Corp. - September 10, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS).
[You may also click here for additional information]
WHY: Faruqi & Faruqi, LLP, a leading national securities law firm, informs investors of the federal securities class action on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period").
WHAT TO DO NEXT: To learn more about the Hims class action, go to www.faruqilaw.com/HIMS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). A class action lawsuit has already been filed.
If you wish to serve as lead plaintiff, you must move the Court no later than November 2, 2026. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
THE ALLEGATIONS:
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company shared consumers' health information with third-party advertising platforms; (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them;" (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Hims's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Frequently Asked Questions (FAQ) for Investors Regarding the Hims Securities Class Action Lawsuit
Who may be eligible to participate in the lawsuit?
Investors who purchased or acquired Hims (NYSE: HIMS) between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
How much did Hims stock drop?
Following the alleged corrective disclosures, Fractyl shares fell approximately 14.73% on July 29, 2026, as described in the complaint.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Hims & Hers Health, Inc. securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313714
Source: Faruqi & Faruqi LLP
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Faruqi & Faruqi LLP or all companies in the Banking / Financial Services industry.
Faruqi & Faruqi, LLP Urges Hims & Hers Health, Inc. (HIMS) Investors to Seek Counsel Before the November 2, 2026 Lead Plaintiff Deadline in the Securities Class Action
2026-09-10 10:05 AM EDT
DVLT EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Datavault AI Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
2026-09-09 9:52 PM EDT
FTK EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Flotek Industries Investors of Securities Class Action Lawsuit Deadline on October 26, 2026
2026-09-09 9:22 PM EDT
Dec 18, 2025
In 2025, more than 39,000 press releases distributed through Newsfile offer a clear lens into how public companies are communicating with the market. At this scale, individual announcements fade into the background, and what emerges instead are patterns . The language companies choose reveals how industries are evolving, where credibility is being built, and what investors are being asked to trust. Last year, this analysis focused on identifying the most common keywords by industry. This...
Litigation and Regulation
Banking / Financial Services